A Tale of Two Markets: Bridging the Gap Between Public and Private Life Sciences Company Valuations

Houlihan Lokey is pleased to present a white paper discussing bridging the gap between public and private life sciences company valuations. In this paper, we will:

  • Explore the ever-evolving landscape of investments in the life sciences sector.
  • Review key trends expected to impact the sector.
  • Discuss methodologies and unique considerations for the valuation of biotech
    companies.
  • Discuss how Houlihan Lokey helps its fund clients navigate private market valuations amid the public market volatility.

*The file is an Adobe Acrobat PDF. If you experience difficulty opening the downloadable file, you may need to download the free Acrobat Reader.

Contact

Susanna O’Brien Managing Director
Susanna O’Brien